Abstract:Background Organoids play an important role in basic research, drug screening, and regenerative medicine. Here, we aimed to develop a novel kind of three-dimensional (3D) organoids generated from urine-derived stem cells (USCs) and to explore whether kidney-specific extracellular matrix (kECM) could enable such organoids for renal function in vitro. Methods USCs were isolated from human urine samples and cultured with kECM extraction to generate 3D organoids in vitro. Eight densities from 1000 to 8000 cells per organoids were prepared, and both ATP assay and Live/Dead staining were used to determine the optimal USC density in forming organoids and kECM additive concentration. The morphology and histology of as-made organoids were evaluated by hematoxylin and eosin (H.E.) staining, immunofluorescence staining and whole mount staining. Additionally, RT-qPCR was implemented to detect renal-related gene expression. Drug toxicity test was conducted to evaluate the potential application for drug screening. The renal organoids generated from whole adult kidney cells were used as a positive control in multiple assessments. Results The optimized cell density to generate ideal USC-derived organoids (USC-organoids) was 5000 cells/well, which was set as applying density in the following experiments. Besides, the optimal concentration of kECM was revealed to be 10%. On this condition, Live/Dead staining showed that USC-organoids were well self-organized without significant cell death. Moreover, H.E. staining showed that compact and viable organoids were generated without obvious necrosis inside organoids, which were very close to renal organoids morphologically. Furthermore, specific proximal tubule marker Aquaporin-1 (AQP1), kidney endocrine product erythropoietin (EPO), kidney glomerular markers Podocin and Synaptopodin were detected positively in USC-organoids with kECM. Nephrotoxicity testing showed that aspirin, penicillin G, and cisplatin could exert drug-induced toxicity on USC-organoids with kECM. Conclusions USC-organoids could be developed from USCs via an optimal procedure. Combining culture with kECM, USC-organoid properties including morphology, histology, and specific gene expression were identified to be similar with real renal organoids. Additionally, USC-organoids posed kECM in vitro showed the potential to be a drug screening tool which might take the place of renal organoids to some extent in the future.

Formation and Optimization of Three-Dimensional Organoids Generated from Urine-Derived Stem Cells for Renal Function in Vitro.

Three-Dimensional Renal Organoids from Whole Kidney Cells: Generation, Optimization, and Potential Application in Nephrotoxicology in Vitro

An efficient method to generate kidney organoids at the air-liquid interface

Growth of embryonic renal parenchyme at the interphase of a polyester artificial interstitium

Kidney organoids: steps towards better organization and function

Development and intra-renal delivery of renal progenitor organoids for effective integration in vivo

Directed differentiation of ureteric bud and collecting duct organoids from human pluripotent stem cells

Kidney Organoid and Microphysiological Kidney Chip Models to Accelerate Drug Development and Reduce Animal Testing

Generation of proximal tubule-enhanced kidney organoids from human pluripotent stem cells

Generation of mitochondria-rich kidney organoids from expandable intermediate mesoderm progenitors reprogrammed from human urine cells under defined medium

Kidney micro-organoids in suspension culture as a scalable source of human pluripotent stem cell-derived kidney cells

Kidney organoids as a promising tool in nephrology

Generation of Human PSC-Derived Kidney Organoids with Patterned Nephron Segments and a De Novo Vascular Network

Recent Advances in Extracellular Matrix Manipulation for Kidney Organoid Research

Generating Kidney Organoids in Suspension from Induced Pluripotent Stem Cells.

In vitro induction and in vivo engraftment of kidney organoids derived from human pluripotent stem cells

Kidney organoids: a pioneering model for kidney diseases

Engineering physiological environments to advance kidney organoid models from human pluripotent stem cells

Organoids as a new model for improving regenerative medicine and cancer personalized therapy in renal diseases

Fine tuning the extracellular environment accelerates the derivation of kidney organoids from human pluripotent stem cells

Engineering kidney developmental trajectory using culture boundary conditions